Emtricitabine Recruiting Phase 4 Trials for Renal Insufficiency,Chronic / Therapeutic Agent Toxicity / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02957864Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
NCT02656511Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
NCT03685500A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
NCT03675815Body Composition Sub-study of the D2EFT Trial